The pathophysiology of cerebral cortical lesions in multiple sclerosis (MS) is not understood. We investigated cerebral cortex microvessels during immune-mediated demyelination in the MS model chronic murine experimental autoimmune encephalomyelitis (EAE) by immunolocalization of the endothelial cell tight junction (TJ) integral proteins claudin-5 and occludin, a structural protein of caveolae, caveolin-1, and the blood-brain barrierYspecific endothelial transporter, Glut 1. In EAE-affected mice, there were areas of extensive subpial demyelination and well-demarcated lesions that extended to deeper cortical layers. Activation of microglia and absence of perivascular inflammatory infiltrates were common in these areas. Microvascular endothelial cells showed increased expression of caveolin-1 and a coincident loss of both claudin-5 and occludin normal junctional staining patterns. At a very early disease stage, claudin-5 molecules tended to cluster and form vacuoles that were also Glut 1 positive; the initially preserved occludin pattern became diffusely cytoplasmic at more advanced stages. Possible internalization of claudin-5 on TJ dismantling was suggested by its coexpression with the autophagosomal marker MAP1LC3A. Loss of TJ integrity was confirmed by fluorescein isothiocyanateYdextran experiments that showed leakage of the tracer into the perivascular neuropil.
INTRODUCTION
Experimental autoimmune encephalomyelitis (EAE) is a laboratory-induced model of inflammatory autoimmune disease of the CNS that is used to investigate the histopathology, neurobiology, and pathogenesis of multiple sclerosis (MS) (1Y4). Despite concerns about the relevance of murine EAE to the corresponding human disease, EAE models are considered invaluable for studies aimed at elucidating pathogenetic mechanisms and for discovery of novel therapeutic interventions (2Y8). Infiltration of the CNS by inflammatory leukocytes and the coincident breakdown of the blood-brain barrier (BBB) are histopathological hallmarks of both MS and EAE. White matter (WM) lesions in MS are typically characterized by perivascular T cell, B cell, and macrophage infiltrates; activation of astrocytes and microglia (9Y12); and increased microvessel permeability, which is not necessarily limited to demyelinated areas (13Y22).
In microvessels of the BBB, the biomechanical gate formed by endothelial tight junctions (TJs) consists of 3 major classes of transmembrane proteins, that is, occludin, claudins, and junctional adhesion molecules, and of TJ-associated adaptor proteins, such as zonula occludens 1 (ZO-1), ZO-2, ZO-3 (23Y27). Altered expression of occludin, junctional adhesion molecules, and ZO-1 has been documented in acute and progressive forms of MS, together with changes in the vascular basement membrane (BM) and pericytes (15, 28Y33) . Inflammation and BBB breakdown are also major features in a variety of EAE models analyzed using different methods in histopathological, biochemical, and magnetic resonance imaging studies. In EAE models, the reduction of occludin, claudin-1, claudin-3, claudin-5, and ZO-1 coincides with the inflammation onset and slightly precedes signs of disease and BBB breakdown (34Y41).
One critical issue in MS studies is the primary involvement of cortical and deep gray matter in the process of demyelination and correlations with typical WM lesions, disease progression, and cognitive decline (42Y46). Improvements in histopathological analysis of postmortem tissues and the availability of advanced magnetic resonance imaging techniques have redefined the MS profile, demonstrating it to be a global CNS disease characterized by demyelinating lesions in gray matter, particularly the neocortex, as well as in WM regions (47Y55). In contrast to WM, leukocyte infiltration and BBB breakdown in the gray matter in MS have been suggested to play a minor role in lesion pathogenesis. In the neocortex, areas of intracortical demyelination are characterized by a moderate inflammatory infiltrate and by scarce evidence of BBB breakdown (44, 47, 56) . Histopathological evidence of cerebral cortex demyelination in EAE was first obtained in rats and marmosets (57Y59) and has recently been demonstrated in EAE induced with the myelin oligodendrocyte glycoprotein (MOG) 35Y55 peptide in C57BL/6 mice (60, 61) . This chronic EAE model is characterized by extensive demyelination of subpial cortex layers and could be a workable tool for exploring BBB dysfunction in a context of reduced direct and/or indirect effects of inflammatory mediators. We used this model to analyze the involvement of BBB microvessels in the damaged cortex by immunolocalization of endothelial caveolin-1, TJ proteins, claudin-5 and occludin, Glut 1 transporter and of astroglia, microglia, and leukocytes using glial fibrillary acidic protein (GFAP), CD11b, and CD45. The study was carried out in 2 groups of mice, at 20 and 39 days postimmunization (dpi), both subdivided into subgroups according to clinical stage scores 1.5 to 2.0 and 2.5 to 3.5. Our results confirm previous observations on cerebral cortical demyelination and oligodendrocyte precursor cell (OPC) proliferation/ activation (60) in this model and further demonstrate scarce perivascular infiltration and BBB breakdown involving claudin-5 reduction as from the first disease signs and occludin damage that occurs later at more severe disease stages.
MATERIALS AND METHODS

Induction of EAE
Procedures involving animals and their care were conducted in conformity with the institutional guidelines in compliance with national (D.L. n. 116, G.U., suppl. 40 later. Control C57BL/6 female mice received either IFA (n = 9) or PTX (n = 5) without MOG 35Y55 ; the latter were included in the experiments to rule out the possibility of toxininduced BBB leakage (62, 63) . Weight and clinical scores (CS) were recorded daily according to the standard EAE grading scale: 0 = healthy; 1 = flaccid tail; 2 = ataxia and/or paresis of hind limbs or slow righting reflex; 3 = paralysis of hind limb and/or paresis of forelimbs; 4 = tetraparalysis; 5 = moribund. The onset of signs was at 13 to 14 dpi. At 6 days after clinical onset, the disease was considered to be in an early phase and was considered to be in a sustained late phase approximately 20 days later. Among the totally immunized mice (n = 28), a first group was killed at early EAE, 20 dpi (n = 5, CS 1.5Y2.0; n = 4, CS 2.5Y3.5); a second group was followed up to 39 dpi, late EAE (n = 2, CS 1.5Y2.0; n = 4, CS 2.5Y3.5). A third group with CS 2.5 to 3 was selected for immunoblotting (20 dpi, n = 1; 39 dpi, n = 2) and fluorescein isothiocyanate (FITC)Ydextran experiments (20 dpi, n = 3; 39 dpi, n = 3). Control mice were killed at equivalent times.
Histology
An archive of free-floating brain sections was developed, as described (60) . Briefly, mice were anesthetized with chloral hydrate (30 KL/g, intraperitoneally) and, with the exclusion of animals selected for FITC-dextran experiments, transcardially perfused with 100 mL of 2% paraformaldehyde (PFA) and 0.2% glutaraldehyde solution. Whole brains were removed and postfixed by immersion in the same fixative at 4-C for 2 hours, then washed in PBS solution, pH 7.6, overnight at 4-C. The analyzed sections were selected from the multiwell archive, which included approximately 120 serial sections (20 Km thick)/hemisphere cut using a vibrating microtome (Leica, Milton Keynes, UK). Blank sections for immunofluorescence staining were selected in the intervals between toluidine blue routinely stained sections.
Immunofluorescence and Laser Confocal Microscopy
Single and multiple immunostainings were carried out with the following primary antibodies: rabbit antiYmyelin basic protein (anti-MBP) (Abcam, Cambridge, UK), mouse IgG 1k anti-70 kd neurofilament (NF) (clone 2F11; Dako Cytomation, Glostrup, Denmark), rabbit IgG and mouse IgG 1 antiYnerveglial antigen 2 (anti-NG2) (Millipore, Billerica, MA), rat IgG 2b anti-CD11b (AbD Serotec, Oxford, UK), mouse IgG 1 anti-GFAP (Vision Biosystem Novocastra, Newcastle-Upon-Tyne, UK), rat IgG 2 anti-CD45 (Novus Biologicals, Inc, Littleton, CO), rabbit antiYcollagen type IV (Acris Antibodies, Hiddenhausen, Germany), rabbit antiYcaveolin-1 (Santa Cruz Biotechnology, Inc, Santa Cruz, CA), mouse IgG 1 antiYclaudin-5 (Zymed Laboratories, Invitrogen Corporation, Carlsbad, CA), rabbit anti-occludin (Zymed Laboratories), rabbit antiGlut 1 (glucose transporter isoform 1; Millipore), sheep anti-MAP1LC3A (microtubule-associated protein light chain 3; Pierce Biotechnology, Rockford, IL) (Table) . After adhesion on polylysine slides (Menzel-Glaser, Braunschweig, Germany) by drying for 10 minutes at room temperature (RT), the sections were submitted to the following protocols: rehydration with PBS for 5 minutes at RT; either protease pretreatment 0.1 mg/mL in PBS for 2 minutes at 37-C (Proteinase K, Code No. 03115879001; Roche, Indianapolis, IN) or heat-induced epitope retrieval by microwave pretreatment in 0.01 mol/L citrate buffer (pH 6.0) for 15 minutes at 750W (when required); incubation with 0.5% Triton X-100 (Merck) in PBS for 30 minutes at RT and with Vector MOM Immunodetection Kit (diluted 35 KL/mL PBS; Vector Laboratories, Burlingame, CA) 1 hour at RT and/or Protein Block Serum Free (Dako) for 15 minutes at RT; incubation with single or combined primary antibodies, diluted in blocking buffer (PBS, 1% bovine serum albumin, 2% FCS; Dako) overnight at 4-C, revealed by appropriate fluorophore-conjugated secondary antibodies (Invitrogen, Eugene, OR) or biotinylated secondary antibodies (Vector) followed by fluorophore-conjugated streptavidin (Invitrogen) diluted in blocking buffer for 45 minutes at RT (Table) . After immunolabeling, the sections were fixed in 4% PFA for 10 minutes and counterstained with either TO-PRO3 diluted 1:10K in PBS (633; Invitrogen) or Sytox Green diluted 1:5K in PBS (488; Invitrogen). After each incubation step, the sections were washed 3 times for 5 minutes with PBS. Finally, the sections were coverslipped with Vectashield (Vector) and sealed with nail varnish. Negative controls were prepared by omitting the primary antibodies, preadsorbing the primary antibodies with an excess of antigen when available, and mismatching the secondary antibodies. The stainings were examined under the Leica TCS SP5 confocal laser scanning microscope (Leica Microsystems, Mannheim, Germany) using a sequential scan procedure. Confocal images were taken at 250-to 500-nm intervals through the z-axis of the sections. Confocal images were taken with 40Â and 63Â oil lenses. Z-stacks of serial optical planes (projection images) and single optical planes were analyzed by Leica confocal software (Multicolor Package; Leica Microsystems).
Immunoblotting
Cerebral cortices were dissected from mice with EAE with CS 2.5 to 3.0 (20 dpi, n = 1; 39 dpi, n = 2) and from control mice (n = 3). The cortices were homogenized with the appropriate lysis buffer (50 mmol/L Tris pH 7.5, 4 mmol/L EDTA, 10% ethylene glycol, 250 mmol/L sucrose, 1 mmol/L dithiothreitol, phenylmethylsulfonyl fluoride). After centrifugation at 10,000g for 15 minutes at 4-C, the proteins (15 Kg/lane) were separated on 12% sodium dodecyl sulfateYpolyacrylamide gel electrophoresis gel, blotted onto nitrocellulose membranes (Amersham Hybond; GE Healthcare, Pittsburgh, PA) and incubated with primary antibodies claudin-5 and occludin (Table) diluted 1:1000 in 5% milk TBS-Tween 0.3%. After washing, horseradish peroxidaseYconjugated secondary antibodies, antimouse (diluted 1:4000; BioRad, München, Germany) and antirabbit (diluted 1:5000, Santa Cruz Biotechnology), were applied for 1 hour at RT. After extensive washing, specific immunoreactivity was visualized with enhanced chemiluminescence Coll IV, type IV collagen; ir, immunoreagent.
reagent. We normalized the densitometric analysis of the Western blots to Ponceau S staining (total loaded protein) using ImageJ software.
FITC-Dextran Experiments
Immunized EAE mice at 20 dpi (n = 3, CS 2.5Y3) and at 39 dpi (n = 3, CS 2.5Y3) and control mice that received either IFA (n = 3) or PTX (n = 5), killed at equivalent times, were used for FITC-dextran experiments to evaluate BBB permeability. A solution of heparin (100 units/kg) plus FITClabeled dextran (5 mg/mL; 71 kd; Sigma) was injected into the tail vein, and after 2 minutes, the mice were killed and brains were dissected and immediately immersed in the fixative solution (2% PFA plus 0.2% glutaraldehyde in PBS, pH 7.4), overnight at 4-C. After brain sectioning, 20-Km-thick slices from EAE brains (20 dpi, n = 1; 39 dpi, n = 1) were immunolabeled using the rabbit antiYcollagen IV (Acris), revealed by a goat anti-rabbit Alexa 488 (Table) . The remaining FITC-dextranY treated brains from mice with EAE (20 dpi, n = 2; 39 dpi, n = 2) were serially sectioned, and, as described earlier, a multiwell archive of 20-Km-thick free-floating sections was developed. Sections at regular intervals were immunolabeled with MBP antibodies, and all the sections for the entire cortex extension were analyzed by confocal microscopy with a 40Â oil lens.
Morphometric Analyses
The sizes of claudin-5Ypositive vacuoles detected in endothelial cells (ECs) of brains of mice with EAE were evaluated with LAS-AF SP5 software (Leica Microsystems) on 63Â magnification fields zoomed 3 times. Vacuole diameter (in nanometers) was measured on claudin-5Ylabeled sections (n = 18) using a mean of 3 stacks per section (each stack resulting from 1 to 3 optical planes) on a total of 460 measured vacuoles. The results were expressed as mean T SD.
RESULTS
Demyelination and OPCs
We initially performed double immunolabeling on brain sections from both 20 dpi and 39 dpi EAE mice with anti-MBP and anti-NF antibodies, focusing on the cerebral cortical layers and using subcortical WM as a reference. These stainings showed a reduction of MBP immunoreactivity in EAE cerebral cortex with a predominance of demyelination in the subpial layers (Fig. 1A , C, D, F); well-demarcated cortex lesions extended to layer IV and to the subcortical WM, respectively (data not shown). These are analogous to type III and type IV lesions described in the cerebral cortex of chronic MS patients (43, 44, 52). At these sites (as well as in subcortical WM), there were axons with partly reduced NF reactivity (Fig. 1B , C, E, F). Because proliferating OPCs have been demonstrated to be a hallmark of EAE in mice, sections adjacent to MBP/ NF-stained sections were immunolabeled for the proteoglycan NG2/CSPG4 (which is widely recognized as an OPC phenotype marker), combined with the microglia marker CD11b and/or the astroglia marker GFAP. We observed a large population of OPCs, characterized by hypertrophic morphology with long, slender, ramified processes and that were well distinguishable from those of the CD11b-positive activated microglia and GFAP-reactive astrocytes in the cerebral cortex of mice with EAE ( Fig. 2A ). There were numerous OPCs with an asymmetric profile in the subpial layer, where they formed processes at the pial surface; around vessels, they formed astrocyte-like end-feet close to the microvessel wall (Fig. 2BYD) . No differences in demyelination were observed between animals at early (20 dpi) and late (39 dpi) disease; at the latter time point, there was a decline in numbers of OPCs.
Astroglia, Microglia, and Monocyte/ Macrophage-Like Cells Double immunolabelings were carried out with GFAP and with CD45 to reveal cellular infiltrates in EAE-affected brains. These were mostly composed of monocyte/macrophagelike cells recognizable for their CD45 high expression and, therefore, distinct from activated microglia characterized by a CD45 low phenotype (64) . In mice with mild or severe disease (CS 1.5Y2.0 or CS 2.5Y3.5), there was a general response to the inflammatory stimuli recognizable in the cerebral cortex also at a distance from the identified areas of demyelination in normal-appearing cortex. Reactive astrocytes were observed in these areas throughout all cortical layers, whereas CD45 high monocyte/macrophage-like cells appeared to be restricted to the subarachnoid and Virchow-Robin spaces and were only rarely seen within the cortex parenchyma ( Fig. 3A; Figure, infiltrates were frequently seen in association with WM microvessels (Fig. 3B) . Analysis of sections adjacent to or corresponding to areas of cortical demyelination demonstrated marked microglial activation throughout all the cortical layers in mice with mild clinical disease (CS 1.5Y2.0) (Fig. 3C, E) , whereas in those with higher clinical scores (CS 2.5Y3.5), cortical demyelination was associated with a detectable, although moderate, infiltrate of CD45 high monocyte/macrophagelike cells scattered in the parenchyma or close to the walls of microvessels (Fig. 3D, F) . Typical dense perivascular infiltrates were only observed in subcortical WM, evident as small cuffs in which the inflammatory cells covered the outer surface of the vascular wall or were entrapped within the inner and outer BM layers ( Figure 
Immunolocalization of Claudin-5 and Occludin
In the cerebral cortex of healthy mice, double immunolabeling for claudin-5 with caveolin-1 showed regular rows of caveolin-1 at the EC surface (Fig. 4A, C, G, I ) and a claudin-5 linear and continuous pattern that revealed inter-EC junctional contacts (Fig. 4B, C, H, I ). Claudin-5 staining defined polygonal areas on the vessel wall and also revealed the point of origin of vascular branches (Fig. 4B, C, H, I ). In mice with both mild and severe EAE, caveolin-1 expression appeared intensified in cortical microvessels in areas with extensive subpial demyelination (Fig. 4D, F, J, L) . In CS 1.5 to 2.0 mice, claudin-5 staining was characterized by a linear, although discontinuous, pattern, together with fluorescent aggregates (Fig. 4E, F) ; in CS 2.5 to 3.5 mice, the linear pattern was lost and only short tracts of claudin-5 reactivity were detectable (Fig. 4K, L) . The microvessels of the subcortical WM, both small venules and periventricular capillaries, showed similar changes of caveolin-1 expression and claudin-5 junctional distribution and a progressive loss of the TJ protein in mice with severe disease (Fig. 5) . In sections double immunolabeled with MBP, the residual claudin-5 frequently appeared to be associated with areas of myelin paucity (Fig. 6) . Moreover, after a careful examination of different cerebral cortex areas, also far from detected sites of cortex demyelination, claudin-5 alterations were observed in microvessels, together with apparently normal junc- The occludin junctional pattern in demyelinated cortex areas appeared initially preserved and changed to a thinner discontinuous reactivity only in mice with severe disease (Fig. 7AYD ). No differences were observed when comparing the claudin-5 and occludin changes in relative expression and distribution in 20 dpi and 39 dpi EAE mice (Figure, Supplemental Digital Content 6, http://links.lww.com/NEN/A383). A close analysis of the altered distribution of claudin-5 provided further details on its staining pattern (Fig. 8AYF) . In cortical microvessels characterized by an almost complete absence of junctional claudin-5, neighboring ECs appeared detached from each other (Fig. 8A, B) ; these findings were often associated with the presence of claudin-5Ypositive aggregates and vacuoles (Fig. 8CYF) . The latter had an estimated diameter of 390.91 T 97.90 nm (mean T SD). These areas of claudin-5 accumulation did not colocalize with caveolin-1. In fact, analysis of EAE and control microvessels on single optical planes only revealed small spots of caveolin-1/claudin-5 colocalization along the endothelial surface profiles (Fig. 9A, B) . In an attempt to obtain a clearer picture of the putative origin of claudin-5 vacuoles, double immunolabelings were also carried out with the BBB-specific transporter Glut 1, used as a marker of the EC plasma membrane, and with the autophagosomal marker MAP1LC3A. Sections subjected to such double staining demonstrated that claudin-5Ylabeled vacuoles always costained for Glut 1 (Fig. 9C, D) and were also colabeled by the marker MAP1LC3A (Fig. 10A, B) . Detailed analysis of occludin carried out with the same approach showed a diffuse cytoplasmic staining but never unveiled occludinreactive aggregates and vacuoles.
Western Blot
To verify whether the reduced junctional immunostaining for TJ proteins of the endothelium corresponded to altered cellular levels of these 2 proteins, Western blot analyses were performed on tissue specimens from healthy and EAE-affected mice with CS 2.5 to 3. Claudin-5 and occludin, detected as bands at 29 kd and 65 kd, respectively, were both downregulated in EAE brains (Fig. 11) . Quantification using optical densitometry revealed a slight reduction of occludin in cortex microvessels of EAE mice, whereas claudin-5 appeared significantly reduced compared with cerebral cortex from healthy mice (p e 0.0001; Fig. 11B ).
Evaluation of BBB Permeability Using an FITC-Dextran Tracer
To evaluate the endothelial junction function in EAE microvessels and to confirm the loss of BBB integrity, tissue fluorescence for the permeability tracer FITC-dextran was analyzed by confocal microscopy on sections immunolabeled for collagen IV in both early and late disease. Two groups of animals were used as controls: healthy mice and PTX-treated mice that had not been immunized with the MOG peptide. In the control animals, the tracer was clearly confined within the lumen of cortical microvessels (Fig. 12AYF) . By contrast, in the cerebral cortex of EAE-affected mice, FITC-dextran was seen as diffuse fluorescence along perivascular spaces and as fluorescent phagocytosis-dependent granules in neuropil cells (Fig. 12GYL) . When the FITC-dextran signal was analyzed in normal-appearing cortex, a moderate microvessel leakage, which involved small venules as well as capillaries, was also recognizable in these areas, together with apparently 
DISCUSSION
Accumulating experimental and clinical data on BBB dysfunction have improved our understanding of CNS inflammatory diseases such as MS and EAE. A number of factors have been identified that determine structural, compositional, and functional TJ abnormalities associated with changes in BBB permeability and leukocyte transvascular migration. Nonetheless, the occurrence and significance of the interplay between the BBB and inflammatory/degenerative factors that contribute to disease heterogeneity remain to be fully elucidated (65, 66) . Previous studies have identified BBB modifications as secondary damage induced by exocrine, leukocyte-derived, and/or paracrine, astrocyte-and microgliaderived, and/or autocrine, endothelium-derived, inflammatory mediators, such as proinflammatory cytokines, interleukin-1A (IL-1A), IL-6, IL-17, IL-22, interferon-F, granulocyte macrophage colony-stimulating factor, tumor necrosis factor, transforming growth factor-A, vascular endothelial growth factor A, reactive oxygen species, and the proinflammatory chemokine CCL2 (67Y75). However, it has also been suggested that BBB dysfunction may precede myelin damage and the onset of inflammation and, as a possible early event, lead to nascent lesions (17, 38, 76Y78) .
Cerebral Cortex EAE
Forebrains of mice with MOG-induced chronic EAE examined during both early and late phases of the disease showed demyelinated intracortical MS-like lesions, astroglial and microglial activation, OPC proliferation, and, despite the rich vascularization of the cortex, a low leukocyte/macrophage infiltrate. Conversely, subcortical and periventricular WM lesions in the same brains were associated with typical perivascular infiltrates. At the cerebral cortical level, the glia limitans laminae superficialis and perivascularis and the glia limitansYassociated BMs seem to restrain CD45 high -reactive FIGURE 4. Cerebral cortex microvessels immunostained with antibodies to caveolin-1 and claudin-5 in control mice (AYC, GYI) and mice with EAE with clinical score (CS) of 1.5 (DYF) or 3 (JYL) at 20 dpi. In healthy mice, endothelial caveolin-1 forms a regular linear pattern (A, C, G, I), whereas in mice with EAE, it accumulates within the endothelial cytoplasm (D, F, J, L). In control microvessels, claudin-5 staining forms a linear and continuous pattern along EC profiles (B, C, H, I) and outlines the sites of branching (H, I; arrow, inset). In CS 1.5 mice, the junctional pattern of claudin-5 is thinner and discontinuous (E, F). In CS 3 mice, claudin-5 is lost and its pattern is only recognizable as rows of fine puncta, also where vessel branches originate (K, L; arrow, inset). Scale bar = 20 Km. monocytes/macrophages that accumulate within the leptomeninges, engulfing the Virchow-Robin space (19, 79) . At these meningovascular gray matter interfaces, specific components of the extracellular matrix (ECM)/BM, there are immunosuppressive cell surface proteins and soluble anti-inflammatory factors that could limit the entry of inflammatory cells (44, 50, 80Y83) . Indirect evidence of possible diversification in ECM/ BM composition in subcortical WM has been provided by the findings of an accumulation of monocytes/macrophages between endothelial and astroglial layers of the BM, which suggests differentially expressed and distributed layer-specific molecules (31, 40, 56, 84Y88) .
TJ Proteins Claudin-5 and Occludin
As demonstrated by the marked impairment of claudin-5 and occludin distributions at the endothelial junctional membranes, the BBB of cortical microvessels is impaired in chronic EAE. Differences in the molecular organization and function of claudin-5 and occludin (16, 19, 25 , 89Y96) might account for the differential response of these 2 TJ molecules in this induced disease. Claudin-5 and occludin are involved at precisely scheduled points of the clinical scoring system and are apparently independent of the disease onset and progression. During both early and late pathology, ''sealing'' claudin-5 is already damaged when the first disease signs appeared, whereas ''regulative'' occludin resists until the development FIGURE 8. Cerebral cortex microvessels immunostained for caveolin-1 and claudin-5 from a control mouse (A) and mice with EAE (BYF). The ECs sealed by claudin-5 in a control microvessel (A) and detached in an EAE microvessel (B), where claudin-5 immunoreactivity also forms large aggregates (CYE, arrowheads) or vacuoles (C, D, F, arrow) along the junctional profile; note a tangentially sectioned EC bearing a large vacuole on its border (arrow) in (F). Scale bar = 10 Km. of severe neurological damage. This modulated response of these TJ proteins, rather than being a general detrimental effect of the disease on the BBB, appears to identify cortical TJ abnormalities that develop during EAE and correlate with clinical disease progression (41) . The presence of EC junctional alterations in apparently normal cortex confirms that this murine EAE model mimics chronic MS, that is, it is characterized by a globally affected brain (15, 18, 29, 43, 44) .
As demonstrated by Western blot analysis and densitometric quantitation, the loss of claudin-5 junctional staining pattern was coupled with a significant reduction of the total protein expression, whereas the junctional immunosignal occludin appeared less damaged. These results suggest that TJ protein degradation occurs in the affected microvessels, together with altered protein distribution in ECs and the formation of aggregates and vacuoles. The latter were demonstrated by claudin-5 reactivity but were never seen in occludin-labeled ECs or in Freund adjuvant only or PTX-treated animals nor in TJ development in normal brain (97) . Disassembly of claudin-5 was further investigated with by double immunolabeling with caveolin-1 (which is involved in TJ protein internalization), the BBB-specific transporter Glut 1, and with MAP1LC3A, a marker of autophagosomes. A preliminary evaluation of cortex EAE microvessel permeability by FITC-dextran experiments reveals a general reduction of the barrier efficacy in these microvessels, disclosed by a well-detectable, although moderate, perivascular diffusion of the permeability tracer and by intracellular fluorescent particles caused by activated microglia, neuronal, and/or astrocyte uptake. The FITC-dextran diffusion and phagocytosis-dependent labeling restricted to single microvessels and to limited parenchymal areas were also detected in apparently normal cerebral cortex. In parallel experiments carried out in normal and PTX controls, FITC-dextran diffusion was never detected, thereby ruling out the possibility of PTX-induced leakage (62, 63) . 
Mechanisms of TJ Protein Dismantling
Tight junction disassembly and remodeling are events of constitutive junctional protein turnover and can also be a response to pathological stimuli, being supported by clathrinand caveolae-mediated endocytosis and macroendocytosis (98Y100). The integral membrane protein caveolin-1, present in raft microdomains and in raft-derived flask-shaped microinvaginations of the plasma membrane known as caveolae, is highly expressed in brain ECs where it is also involved in socalled scaffolding rafts associated with endothelial TJs (32, 90, 101Y103) . Variations of caveolin-1, either loss or increase of the molecule within the cell, can modulate TJ protein mobilization and BBB integrity according to specific conditions and with different effects in different experimental models (100, 102, 104Y107). Moreover, the specific junction rearrangement pathway depends on the cell type (e.g. epithelial vs brain ECs) on the inducing stimuli and on the protein structure and localization (100, 108) . The dynamics of claudin-5 and occludin internalization are driven by caveolin-1Ydependent endocytosis, which for occludin involves the >-helix coiledcoil structure of its C-terminal domain (95, 100, 109) . This mechanism is revealed in control and EAE cortex microvessels as focal points of claudin-5/caveolin-1 colocalization that do not show an appreciable increase in EAE, despite the overexpression of caveolin-1 in the disease. A unique aspect of EAE TJ protein dismantling that apparently is independent of caveolae-and coated vesicleYmediated endocytosis is the presence of endothelial claudin-5/Glut 1Ydecorated vacuoles of approximately 390-nm diameter, formed by junctional cell membranes with a rich Glut 1 content (110, 111) . Vacuole formation could be related to the junctional molecular organization of claudin-5. In fact, as demonstrated by fluorescence resonance energy transfer, the TJ-type extracellular loop 2 of claudin-5 is involved in junctional strand formation and physically seals the interendothelial clefts via homophilic cis-and trans-dimer interactions (94, 95, 112) . The structural continuity of the junctional endothelial plasma membrane of opposing cells sealed by claudin-5 transinteractions may allow coendocytosis of both the claudin-5Ybearing membranes into one of the adjacent cells and compulsory cell detachment (113) . Interestingly, unlike claudin-5, occludin does not form endothelial vacuoles, supporting the finding that claudins can be selectively segregated from other TJ components and internalized in junctional membrane vacuoles to be targeted to a storage compartment and eventually recycled (113) . A possible significance of claudin-5Ypositive vacuoles is indicated by their colocalization with the autophagosomal marker MAP1LC3A, which suggests the involvement of single-membrane vacuoles of an autophagosomal nature in disease-dependent dismantling of entire claudin junctional territories (114Y117).
OPCs and BBB Dysfunction
This last consideration brings us back to one of our initial results, that is, the presence in the cerebral cortex of mice with EAE of an increased number of NG2-positive OPCs, a phenotypically well-defined cell population in developing and adult brains (118) . The proliferative response of OPCs in EAE may be an attempt to support remyelination, the failure of which has been suggested to depend on a maturation block internal to the oligodendrocyte lineage (60) that, in turn, could be conditioned by impaired BBB function (55, 119, 120) . Differences and similarities of OPCs with other macroglia and microglia cell types make the study of the possible role of these cells in the EAE microvessel disease of interest. In vitro and in vivo studies have yielded contradictory results with respect to OPC progeny and the possible overlapping of astrocyte/OPC phenotypes and functions; in normal conditions, low levels of GFAP mRNA have been detected in NG2-glial cells, and a contribution of OPCs to pial and vascular glia limitans has been excluded (121Y125). By contrast, our data suggest that in EAE, OPCs not only proliferate and differentiate but also assume a critical position with respect to the meningovascular interfaces, always remaining quite distinct from GFAP astrocytes. We observed that, in EAE, perivascular OPCs are collected around cortical microvessels and display astrocyte-like end-feet; at this site, they become part of the neurovascular unit and may interact with its cellular (ECs, pericytes, astrocytes) and noncellular (BM molecules) components, participating in the neurovascular unit crosstalk (20, 126Y129) . Endothelial-OPC interaction promotes OPC survival and proliferation (130) , and, vice versa, these immature OPCs originated by a self-renewal capacity and by glial restricted progenitors could interfere with neurovascular unit cell-cell signaling, affecting TJ regulation and maintenance. Like immature activated pericytes, OPCs express NG2, a chondroitin sulfate transmembrane proteoglycan that has been demonstrated to be involved in vessel growth in different models of induced angiogenesis (131Y133) and that could have a role in endothelial TJ regulation through its ability to influence cell-ECM interactions by modulating FIGURE 11 . (A, B) Claudin-5 and occludin expression levels determined by Western blotting (A) and quantification using optical densitometry (B) on cerebral tissue from control mice and mice with EAE. Occludin (65 kd) bands are slightly reduced; the densitometric data do not show significant differences between occludin levels in control versus EAE brains. Claudin-5 appeared significantly reduced compared with cerebral cortex from healthy mice (p e 0.0001).
endothelial A 1 -integrin activity and cell linkage to vascular BM collagens IV/VI (133Y135).
CONCLUSIONS
Our results indicate that the EAE model adopted is suitable for analysis of the cerebral cortical BBB in CNS inflammatory/neurodegenerative diseases. Studying modifications of the cerebral cortex microvessel structure under the influence of mild inflammation may provide a means to dissect the role of BBB disruption in the pathogenesis of disorders and provide a better understanding of pathogenetic vascular mechanisms. Whereas it is plausible that loss of TJ integrity could be related to the release of cytokines from inflammatory cells located in subcortical WM and/or activated microglia, the possibility that an independent microvascular disease may actively interact with other disease effectors should also be considered. Further investigations will be needed to elucidate possible effects of OPCs on the BBB in CNS inflammatory/demyelinating diseases.
